SCHEMBL7309478

SCHEMBL7309478

CCCCCCC[C@H](O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 7/20 1.00
▸ FFAR1 O14842 2/20 1.00
▸ MAPT P10636 1/20 0.59
▸ LCK P06239 1/20 0.59
▸ PPARD Q03181 1/20 0.59
▸ ZDHHC20 Q5W0Z9 1/20 0.59
▸ ZDHHC2 Q9UIJ5 1/20 0.59
▸ FFAR4 Q5NUL3 1/20 0.55
▸ ACE2 Q9BYF1 1/20 0.55
▸ GRIK1 P39086 1/20 0.50
▸ GRIK2 Q13002 1/20 0.50
▸ S1PR2 O95136 1/20 0.49
▸ S1PR4 O95977 1/20 0.49
▸ S1PR1 P21453 1/20 0.49
▸ S1PR3 Q99500 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5920648 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL17786 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7990074 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL525378 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL524846 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL338215 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL123324 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL4424351 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL6242099 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL6238780 1.00 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575844-B1 Hydroxamic acid derivatives and pharmaceutical compositions thereof HOFFMANN LA ROCHE (CH) 1998-01-21 — — EP disclosed
EP-0575844-A2 Hydroxamic acid derivatives and pharmaceutical compositions thereof F. HOFFMANN-LA ROCHE AG (CH) 1993-12-29 — — EP disclosed
Send feedback